Fig. 5
From: First-in-human dosimetry and safety evaluation of 68Ga-αMSH derivative for PET imaging of melanoma
PET/CT images of a 63-year-old female patient with histologically confirmed stage IV metastatic melanoma. The patient was referred for evaluation of suspected disease progression. (A) Image acquired at 60 min post-injection of [68Ga]Ga-CCZ01048; (B) image acquired at 120 min post-injection. The scan revealed widespread metastatic involvement, including the brain, lungs, stomach, lymph nodes, and subcutaneous tissues. Notable findings include a hypermetabolic lesion near the fourth ventricle, multiple pulmonary metastases, focal gastric wall thickening along the greater curvature, extensive lymphadenopathy in the left iliac chain, and tumor nodules in the subcutaneous fat of the foot.
